tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Revenue

Compare
1,592 Followers

Coherus Biosciences Revenue

Coherus Biosciences had a revenue of 7.60M in the quarter ending Mar 31, 2025, with -85.97%. This bring the company's revenue in the last twelve months to 197.50M, Increased -26.02%. In the fiscal year ending Dec 31, 2024, Coherus Biosciences had annual revenue of 266.96M with 3.78% growth.
Revenue (ttm)
197.50M
Revenue Growth
-34.58%
P/S Ratio
0.32
Revenue/Employee
$1,170,877
Employees
228
Market Cap
$86.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
266.96M9.72M+3.78%
Dec 31, 2023
257.24M46.20M+21.89%
Dec 31, 2022
211.04M-115.51M-35.37%
Dec 31, 2021
326.55M-149.27M-31.37%
Dec 31, 2020
475.82M119.75M+33.63%
Dec 31, 2019
356.07M354.51M+22,783.74%
Dec 31, 2018
1.56M0.00%
Dec 31, 2017
1.56M-188.55M-99.18%
Dec 31, 2016
190.11M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis